ceiving total parenteral nutrition. The mean glutamine concentration in cerebrospinal fluid in the reference oup was somewhat lower than values reported for older children and adufts. Values were significantly higher in patients with meningitis or cerebral hemorrhage and in those infants receiving total parenteral nutrition. 
Materials and Methods

Patients
We used some samples of CSF in this study that had been collected for the diagnosis of illnesses unrelated to hyperammonemia or hepatic encephalopathy.
The samples were divided into four groups ( Table 1) .
The first group of samples was from patients who did not have meningitis or cerebral hemorrhage and were not receiving total parenteral nutrition. A breakdown of the clinical diagnoses of patients in this group is shown in Table 1 . This group was further subdivided into four age groups ( Table 2 ). The second group consisted only of patients receiving total parenteral nutrition at the time that their samples were collected. The infants in this group ranged in age from newborn to six months of age and were receiving total parenteral nutrition as part of the treatment for the complications of prematurity. The third group included all patients whose final diagnosis was meningitis. Table 1 indicates which organisms were isolated in each case. We did not attempt to identify at which stage of the course of the illness the sample was taken.
The fourth group included all patients who had evidence of cerebral hemorrhage.
Materials
CSF glutamine was assayed as described by Glasgow and Dhiensiri (6) . Glutaminase (EC 3.5.1.2; Grade V) and L-glutamine were purchased from Sigma Chemical Co., St. Louis, MO 63178. A working solution of glutaminase was prepared by adding 3.6 rnL of 50 mmol/L sodium acetate buffer, pH 4.9, to a vial containing 10 U of glutaminase.
The glutamine standard solution was prepared by dissolving 50 mg of Lglutamine in 100 mL of de-ionized water. Working standard solutions, 100 and 200 mgfL, were prepared from this 500 mg/L stock solution.
The phenol color reagent was prepared by dissolving 50 g of phenol and 0.25 g of sodium nitroprusside in 1 L of deionized water.
The alkaline hypochlorite reagent was prepared by dissolving 25 g of sodium hydroxide and 2.1 g of sodium hypochlorite in 1 L of de-ionized water.
Method
Add 20 sL of water (blank), standard solution, or CSF to 200 tL of glutaminase solution and mix. Incubate the mixture for 30 min at 37 #{176}C, then terminate the reaction by adding 1 mL of phenol reagent and 1 mL of alkaline hypochlorite reagent. After mixing, then incubating for another 30 mm at 37 measure the absorbance of the resulting indophenol at 640 nm. Calculate results by reference to a standard curve prepared from aqueous L-glutamine solutions of 0 to 500 mgfL (Figure 2) . Peters (12) .
The statistical significance of any differences between groups was determined by the non-parametric Mann-WhitneyUtest (13) . Figure 3 ). Although we found no significant difference between newborns (younger than 15 days) and the group of infants ranging in age from 15 days to six months, the mean CSF glutamine concentrations in the 15-day to six-month, six-to 12-month, and 12-to 30-month groups differed significantly from one another ( Table 2) .
Results
The
Results for the group of patients receiving total parenteral nutrition were significantly (p <0.005) higher than for the whole reference group. Results ranged from 60 to 268 mg/L with a mean of 135 (SD 64) mg/L. Samples from the meningitis group included fluids with both normal and supranormal protein content. We measured protein concentration in a Ca-:: The patients with cerebral hemorrhage had CSF glutamine concentrations ranging from 73 to 314 mg/L, with a mean of 195 (SD 87) mg/L. In this group also, CSF glutamine concentration significantly (p <0.005) exceeded the mean for the whole reference group.
Discussion
Defects in ammonia metabolism are common in several illnesses of neonates. Hyperammonemia has been described in urea-cycle disorders (14) , hypovolemic shock (15), congestive heart failure (16), erythroblastosis fetalis (17), respiratory distress syndrome (10) , and perinatal asphyxia (11) , in addition to hepatic failure.
The concentration of ammonia in venous blood is not a direct index to brain ammonia concentrations, because the rate at which the brain takes up ammonia is a complex function of several metabolic and anatomical factors (2) . Moreover, blood ammonia concentration is poorly correlated with degree of encephalopathy (18, 19) . On the other hand, the concentration of CSF glutamine correlates well with the presence and degree of hepatic encephalopathy
Measurement
of CSF glutamine is technically easier than measurement of blood ammonia, and adequate amounts of CSF are usually available during the routine laboratory diagnosis of encephalopathy; thus this test is valuable and easily applicable to the investigation of encephalopathy.
We routinely make use of this test in our hospital for this purpose.
Measurement of CSF glutamine in the investigation of hyperammonemic encephalopathies in infants demands that accurate reference values be available for this age group. Furthermore, the specificity of the test for hyperammonemic encephalopathy must be clearly understood. Cerebral hemorrhage and meningitis are also common causes of coma in this age group, and the high proportion of encephalopathic preterm infants receiving total parenteral nutrition in intensive-care nurseries is another factor to be considered in intorprting thisteit.
Even with reference values available for the infant age group, the above-mentioned factors clearly can alter the interpretation of test data, because these conditions can significantly increase the glutamine concentration in CSF into the range observed in hepatic coma (5) and Reye's syndrome (6, 8) .
We plan to investigate factors causing increased CSF glutamine in meningitis and cerebral hemorrhage.
